Mallinckrodt

Global biopharmaceutical company Mallinckrodt plc announced the publication of findings from a retrospective medical records study assessing the real-world utilization and outcomes of Acthar Gel (repository corticotropin injection) in patients with refractory rheumatoid arthritis (RA) that did not adequately respond to standard-of-care therapies.

Prescriptions for nerve pain medicines like Neurontin and Lyrica more than tripled in recent years, driven by increased use among chronically ill older adults and patients already taking opioids, a U.S. study suggests.

Regular use of pain relievers over many years may increase the risk of hearing loss, a recent study suggests.

The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for a form of blood cancer. […]

(Reuters Health) – In a new study, people who arrive at the emergency room with severe low back pain didn’t experience more relief with muscle relaxants or opioids than with […]

People who have been treated for colon cancer are less likely to get chemotherapy after surgery to reduce the risk of future cancer if they have to travel far for […]

Taking one or two baby aspirins a day for at least five years was tied to a lower risk of colorectal cancer in a study from Denmark. Earlier studies had […]